...
首页> 外文期刊>Journal of the mechanical behavior of biomedical materials >Development and effect of different bioactive silicate glass scaffolds: In vitro evaluation for use as a bone drug delivery system
【24h】

Development and effect of different bioactive silicate glass scaffolds: In vitro evaluation for use as a bone drug delivery system

机译:不同生物活性硅酸盐玻璃支架的开发和效果:用作骨药物递送系统的体外评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Local drug delivery systems to bone have attracted appreciable attention due to their efficacy to improve drug delivery, healing and regeneration. In this paper, development and characterization of new formulations of bioactive glass into a porous scaffold has been reported for its suitability to act as a drug delivery system in the management of bone infections, in vitro. Two new glass compositions based on Si02-Na20-Zn0-Ca0-Mg0-P205 system (BGZ and MBG) have been developed which after thorough chemical and phase evaluation, studied for acellular static in vitro bioactivity in SBF. Porous scaffolds made of these glasses have been fabricated and characterized thoroughly for bioactivity study, SEM, XRD, in vitro cytotoxicity, MTT assay and wound healing assay using human osteocarcoma cells. Finally, gatifloxacin was loaded into the porous scaffold by vacuum infiltration method and in vitro drug release kinetics have been studied with varying parameters including dissolution medium (PBS and SBF) and with/without impregnation chitosan. Suitable model has also been proposed for the kinetics. 63-66% porous and 5-50 |im almost unimodal porous MBG and BGZ bioactive glass scaffolds were capable of releasing drugs successfully for 43 days at concentrations to treat orthopedic infections. In addition, it was also observed that the release of drug followed Peppas-Korsmeyer release pattern based on Fickian diffusion, while 0.5-1% chitosan coating on the scaffolds decreased the burst release and overall release of drug. The results also indicated that MBG based scaffolds were bioactive, biocompatible, noncytotoxic and exhibited excellent wound healing potential while BGZ was mildly cytotoxic with moderate wound healing potential. These results strongly suggest that MBG scaffolds appear to be a suitable bone drug delivery system in orthopedic infections treatment and as bone void fillers, but BGZ should be handled with caution or studied elaborately in detail further to ascertain and confirm the cytotoxic nature and wound healing potential of this glass.
机译:由于局部药物递送系统具有改善药物递送,愈合和再生的功效,因此引起了人们的关注。在本文中,已经报道了将生物活性玻璃的新配方开发和表征为多孔支架的特性,因为它适合用作体外骨感染管理中的药物递送系统。已经开发了基于SiO 2 -Na 20 -Zn 0 -Ca 0 -Mg 0 -P 2 O 5系统的两种新的玻璃组合物(BGZ和MBG),其经过彻底的化学和相评估,研究了SBF中的无细胞静态体外生物活性。用这些玻璃制成的多孔支架已被制造并彻底表征,以用于生物活性研究,SEM,XRD,体外细胞毒性,MTT测定和使用人骨肉瘤细胞的伤口愈合测定。最后,将加替沙星通过真空渗透法加载到多孔支架中,并在包括溶出介质(PBS和SBF)在内的各种参数下以及有/无浸渍壳聚糖的条件下研究了体外药物释放动力学。还已经为动力学提出了合适的模型。 63-66%的多孔和5-50 im几乎单峰的多孔MBG和BGZ生物活性玻璃支架能够在43天内成功释放药物,以治疗骨科感染。此外,还观察到药物的释放遵循基于Fickian扩散的Peppas-Korsmeyer释放模式,而支架上0.5-1%的壳聚糖涂层降低了药物的突释释放和总体释放。结果还表明,基于MBG的支架具有生物活性,生物相容性,无细胞毒性并显示出优异的伤口愈合潜力,而BGZ具有轻度的细胞毒性和中等的伤口愈合潜力。这些结果强烈表明,MBG支架似乎是骨科感染治疗中的合适骨药物输送系统,并且可以作为骨空隙填充物,但应谨慎对待BGZ或进一步详细研究BGZ,以确定并确认其细胞毒性性质和伤口愈合潜力这杯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号